Home/Sporos Biodiscovery/Sharon Shacham, Ph.D.
SS

Sharon Shacham, Ph.D.

Consulting Lead Scientist

Sporos Biodiscovery

Therapeutic Areas

Sporos Biodiscovery Pipeline

DrugIndicationPhase
SPR1Cancers with Hippo-driver mutations/aberrations & YAP/TAZ hyperactivationIND Enabling
SPR2Cancers resistant to immunotherapyDiscovery in Vitro
SPR3Cancers resistant to MAPK inhibition and/or immunotherapyDiscovery in Vitro
SPR4PTEN-deficient cancersDiscovery in Vitro